ArticleScientific reports2025
Controlled electrochemical fabrication of large and stable gold nanorods with reduced cytotoxicity.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Gold Nanoparticles in Prostate Cancer: Advances in Targeted Therapy, Diagnostics, and Precision Nanomedicine.Pharmaceuticals (Basel, Switzerland) · 2026Review
- Ultra-sensitive nanostructured electrochemical immunosensor for selective monitoring of L-phenylalanine in phenylketonuria patients.Mikrochimica acta · 2026Article
- Femtogram-level VEGF detection via PEG-directed gold nanostructured electrochemical immunosensor.Scientific reports · 2025Article
- Synergistic chemo-photothermal therapy using doxorubicin-loaded gold nanorods for enhanced apoptosis in lung cancer cells.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gold nanorods (GNRs) are valued for their tunable surface plasmon resonance (SPR) and unique optical properties, but precise control over their size and shape remains challenging. Current synthesis techniques often yield polydisperse samples and require high concentrations of cytotoxic surfactants, limiting their biomedical applications. In this study, we introduce a novel electrochemical synthesis method that offers precise control of GNR characteristics by leveraging open circuit potential (OCP) data from colloidal synthesis. This approach involves the electrochemical growth of gold nano-seeds immobilized on fluorine-doped tin oxide (FTO) substrates, using physical vapor deposition (PVD) followed by thermal annealing to generate the Au seeds. This eliminates the need for seed solutions and significantly reduces surfactant usage. By optimizing electrochemical parameters, we produce uniform GNRs up to 700 nm in length, surpassing the typical 100 nm size from traditional methods. These larger GNRs exhibit superior optical and thermal properties, making them ideal for biomedical imaging, photothermal therapy, and applications requiring deeper tissue penetration. Their increased size also enhances stability, biosensing sensitivity, and circulation time, making them suitable for drug delivery and catalysis. This scalable method improves nanorod growth understanding while addressing cytotoxicity concerns.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.